Patent · US Expired

HCV peptide antigens and methods for the determination of HCV

US6183949A · kind A · utility

7Cited by

4References

2Claims

0Family size

Assignee

Roche Diagnostics GMBH · DE

Inventors

Christoph Seidel · Weilheim, DE
Gertraud Ehrlich-Weinreich · Deggendorf, DE
Hubert Bayer · Weilheim, DE
Ursula-Henrike Wienhues · Krailling, DE
Gunther Jung · Tübingen, DE
Hans-Georg Ihlenfeldt · Iffeldorf, DE

Key dates

Filing date	Feb 21, 1996
Grant date	Feb 6, 2001
Priority date	—
Expiry date	Feb 21, 2016

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/24222
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel HCV peptide antigens are described representing partial sequences of the C-100-3 and env/core with C-regions. These peptide antigens are suitable for the determination of HCV antibodies as immunogens for the production of antibodies against HCV and as vaccines for the production of vaccines against HCV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.